149 related articles for article (PubMed ID: 29103242)
1. Prevalence and Genotype Distribution of HPV Types in Women at Risk for Cervical Neoplasia in Israel.
Siegler E; Shiner M; Segev Y; Mackuli L; Lahat N; Lavie O
Isr Med Assoc J; 2017 Oct; 19(10):635-639. PubMed ID: 29103242
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of HPV types in women with CIN 2-3 or cervical cancer in Haifa district, Israel.
Siegler E; Sharir K; Lavie O; Saked-Misan P; Machulki L; Auslender R; Segev Y
Minerva Ginecol; 2017 Jun; 69(3):211-217. PubMed ID: 27636902
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
4. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
5. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
Wong AK; Chan RC; Nichols WS; Bose S
Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
[TBL] [Abstract][Full Text] [Related]
6. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
[TBL] [Abstract][Full Text] [Related]
7. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
[TBL] [Abstract][Full Text] [Related]
8. Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
Tracht JM; Davis AD; Fasciano DN; Eltoum IA
Cancer Cytopathol; 2017 Oct; 125(10):795-805. PubMed ID: 28817235
[TBL] [Abstract][Full Text] [Related]
9. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
Dane C; Batmaz G; Dane B; Cetin A
Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
[TBL] [Abstract][Full Text] [Related]
10. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
11. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
12. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
13. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
[TBL] [Abstract][Full Text] [Related]
15. A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science.
Allameh T; Moghim S; Asadi-Zeidabadi M
Arch Gynecol Obstet; 2011 Dec; 284(6):1509-13. PubMed ID: 21387088
[TBL] [Abstract][Full Text] [Related]
16. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human papillomavirus and the correlation of HPV infection with cervical disease in Weihai, China.
Yang L; He Z; Huang XY; Liu HN; Tao JY
Eur J Gynaecol Oncol; 2015; 36(1):73-7. PubMed ID: 25872339
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
Ren C; Zhu Y; Yang L; Zhang X; Liu L; Ren C
Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
[TBL] [Abstract][Full Text] [Related]
20. Association between HPV types and species groups and cervical neoplasia from a high-risk area for cervical cancer, GoiĆ¢nia, Brazil.
Ribeiro AA; Figueiredo Alves RR; Costa MC; Villa LL; Zeferino LC; Mauricette Derchain SF; Dos Santos Carneiro MA; Rabelo-Santos SH
Int J Gynecol Pathol; 2011 May; 30(3):288-94. PubMed ID: 21464724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]